Publicaciones en VIVO

Mapa de la ciencia

Red de Coinvestigador

PLANELLS CASES, ROSA MARIA

Person

Positions

Profesor/a Colaborador/a, Bioquímica y Biología Molecular 2002 - 2004
PDI INVESTIGADOR, Instituto de Biología Molecular y Celular 2003
Ayudante de Universidad, Bioquímica y Biología Molecular 2000 - 2002
Ayudante de Universidad, DPTO. NEUROQUIMICA 1997 - 2000

Publications
Research
Teaching
Contact
Ver todos

supported publications or other works

IDENTIFICACION DE COMPLEJOS MOLECULARES ENTRE EL RECEPTOR A CAPSAICINA (TRPV1) Y PROTEINAS CON DOMINIOS PDZ 2006

selected publications

academic article
- Pharmacological intervention at ionotropic glutamate receptors. CURRENT PHARMACEUTICAL DESIGN. 3583-3596. 2006
- functional aspects and mechanisms of trpv1 involvement in neurogenic inflammation that leads to thermal hyperalgesia. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY. 151-159. 2005
- Identification of a tetramerization domain in the C-terminus of the the vanilloid receptor. JOURNAL OF NEUROSCIENCE. 5307-5314. 2004
- Modulation of botulinum neurotoxin A catalytic domain by tyrosine phosphorylation. FEBS LETTERS. 121-127. 2004
- Molecular architecture of the vanilloid receptor: insights for drug design. EUROPEAN JOURNAL OF BIOCHEMISTRY. 1820-1826. 2004
- Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity. JOURNAL OF BIOLOGICAL CHEMISTRY. 25665-25672. 2004
- GAP43 is an osmotic-dependent activator of inositol triphosphate-mediated Ca2+-release. EMBO JOURNAL. 3004-3014. 2003
- Small molecules targeting the vanilloid receptor complex as drugs for inflammatory pain. DRUG FUTURE. 23-28. 2003
- A novel N-Methyl-D-aspartate receptor open channel blocker with in vivo neuroprotectant activity.. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 163-173. 2002
- Attenuation of Chemical and Thermal Nociception and Hyperalgesia by Novel VR1 Blockers.. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES. 2374-2379. 2002
- Attenuation of chemical and thermal nociception and hyperalgesia by novel VR1 blockers.. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AME. 2374-2379. 2002
- Prevention of in vivo excitotoxicity by a family of trialkylglicines, a novel class of neuroprotectants.. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 29-36. 2002
- A family of trialkylglycines with in vitro and in vivo neuroprotective activity against excitotoxicity.. SOCIETY FOR NEUROSCIENCE ABSTRACTS. 2001
- A member of the HIT protein family interacts with VR-1 Society for Neurosciences.. SOCIETY FOR NEUROSCIENCE ABSTRACTS. 2001
- Structural adaptability between the putative voltage sensor of Kv channels and the prokaryotic HCSA channel.. JOURNAL OF BIOLOGICAL CHEMISTRY. 21070-21076. 2001
- Thermal stabilization of the catalytic domain of Botulinum Neurotoxin E by phosphosylation of a single tyrosine residue.. BIOCHEMISTRY. 2234-2242. 2001
- Arginine rich peptides are blockers of VR-1 channels with analgesic activity. FEBS LETTERS. 131-136. 2000
- Identification of VR-1 channel blockers that exhibit analgesic activity.. EUROPEAN JOURNAL OF NEUROSCIENCE. 2000
congress communication
patent

presentations

invited conference
- Intracellular chloride channels in neurodegeneration, Conferencia 2003
- Estudios estructura-funcion en canales ionicos., Conferencia